— Know what they know.
Not Investment Advice

BBNX NASDAQ

Beta Bionics, Inc.
1W: -11.8% 1M: -2.4% 3M: +13.4% YTD: -35.2% 1Y: -6.2%
$18.96
+0.09 (+0.48%)
 
Weekly Expected Move ±13.4%
$14 $16 $19 $22 $24
NASDAQ · Healthcare · Medical - Devices · Tech Score Neutral · Power 42 · $853.0M mcap · 20M float · 6.06% daily turnover · Short 61% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
49.6 / 100
NoneWeakNarrowWide
Primary source: Switching Costs  ·  ROIC: -79.6%
Cost Advantage
42
Intangibles
43
Switching Cost
75
Network Effect
43
Scale
35
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. BBNX shows a Weak competitive edge (49.6/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Switching Costs. Negative ROIC of -79.6% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$16
Low
$24
Avg Target
$28
High
Based on 5 analysts since Jul 29, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 6Hold: 2Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$22.75
Analysts8
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-09-23 Wells Fargo — Initiated $28 — +22.8% $22.81
2026-09-15 Truist Financial Richard Newitter $22 $23 +1 +37.5% $16.73
2026-09-15 Robert W. Baird — $14 $16 +2 -4.4% $16.73
2026-09-15 UBS — $22 $25 +3 +49.4% $16.73
2026-09-14 Leerink Partners Mike Kratky Initiated $27 — +54.0% $17.53
2026-07-28 UBS Patrick Wood $24 $22 -2 +37.6% $15.99
2026-07-15 Goldman Sachs — $17 $19 +2 +12.7% $16.86
2026-07-13 Truist Financial — $25 $22 -3 +27.5% $17.26
2026-05-27 Goldman Sachs — $25 $17 -8 +45.1% $11.72
2026-02-18 Lake Street — $40 $20 -20 +60.7% $12.45
2026-02-18 Robert W. Baird — $28 $14 -14 +0.2% $13.97
2026-02-18 Stifel Nicolaus Jonathan Block $25 $22 -3 +57.5% $13.97
2026-02-08 UBS — Initiated $24 — +83.5% $13.08
2026-02-04 Stifel Nicolaus — $31 $25 -6 +77.8% $14.06
2026-02-02 Truist Financial — $37 $25 -12 +79.9% $13.89
2026-01-26 Cowen & Co. — Initiated $17 — +10.0% $15.46
2026-01-15 Goldman Sachs David Roman $33 $25 -8 +47.1% $16.99
2026-01-09 Lake Street — $35 $40 +5 +88.1% $21.26
2025-12-18 Truist Financial Richard Newitter $32 $37 +5 +21.5% $30.45
2025-12-16 Robert W. Baird — $23 $28 +5 -5.8% $29.73
2025-10-29 Lake Street Frank Takkinen Initiated $35 — +44.2% $24.28
2025-10-29 Stifel Nicolaus Jonathan Block Initiated $31 — +27.7% $24.28
2025-10-29 Goldman Sachs David Roman $26 $33 +7 +35.9% $24.28
2025-10-29 Robert W. Baird — $17 $23 +6 -5.3% $24.28
2025-10-29 Piper Sandler Matt O'Brien Initiated $32 — +13.0% $28.32
2025-10-29 Truist Financial Richard Newitter Initiated $32 — +31.8% $24.28
2025-10-01 Goldman Sachs — Initiated $26 — +30.9% $19.87
2025-07-30 Robert W. Baird — Initiated $17 — +1.4% $16.76

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-
Oct 02, 2026
DCF
1
ROE
1
ROA
1
D/E
2
P/E
1
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. BBNX receives an overall rating of C-. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (2/5), P/E (1/5).
Rating Change History
DateFromTo
2026-10-01 C C-
2026-07-30 C- C
2026-07-29 C+ C-
2026-07-01 C C+
2026-04-21 C- C
2026-04-01 C C-
2026-03-02 C- C
2026-02-19 D+ C-
2026-02-18 C D+
2026-02-17 C- C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 40 Grade D
Profitability
18
Balance Sheet
84
Earnings Quality
55
Growth
52
Value
38
Momentum
50
Safety
100
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. BBNX scores highest in Safety (100/100) and lowest in Profitability (18/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
10.04
Safe Zone
Piotroski F-Score
3/9
✗ ✗ ✗ ✓ ✗ ✗ ✗ ✓ ✓
Beneish M-Score
-2.02
Unlikely Manipulator
Ohlson O-Score
-5.67
Bankruptcy prob: 0.3%
Low Risk
Credit Rating
A
Score: 74.7/100
Trend: Stable
Earnings Quality
—
OCF/NI: 0.76x
Accruals: -5.5%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. BBNX scores 10.04, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. BBNX scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. BBNX's score of -2.02 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. BBNX's implied 0.3% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. BBNX receives an estimated rating of A (score: 74.7/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-11.29x
PEG
9.18x
P/S
7.17x
P/B
3.29x
P/FCF
-11.37x
P/OCF
—
EV/EBITDA
-7.30x
EV/Revenue
4.40x
EV/EBIT
-6.97x
EV/FCF
-8.53x
Earnings Yield
-10.45%
FCF Yield
-8.80%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. BBNX currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
0.971
EBT / EBIT
×
EBIT Margin
-0.631
EBIT / Rev
×
Asset Turnover
0.382
Rev / Assets
×
Equity Multiplier
1.115
Assets / Equity
=
ROE
-26.2%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. BBNX's ROE of -26.2% is driven by Asset Turnover (0.382), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 421 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$18.96
Median 1Y
$11.45
5th Pctile
$2.65
95th Pctile
$49.44
Ann. Volatility
86.6%
Analyst Target
$22.75
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
420
+44.3% YoY
Revenue / Employee
$238,693
Rev: $100,251,000
Profit / Employee
$-174,286
NI: $-73,200,000
SGA / Employee
$220,069
Avg labor cost proxy
R&D / Employee
$82,831
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -9.1% -15.1% -20.3% -25.5% -22.7% -26.2% -26.16%
ROA -8.5% -13.8% -18.1% -22.3% -20.7% -23.5% -23.45%
ROIC -16.5% -51.9% -59.5% -69.9% -77.7% -79.6% -79.60%
ROCE -5.8% -11.4% -16.3% -21.2% -23.6% -28.2% -28.21%
Gross Margin 50.9% 53.8% 55.5% 59.0% 59.5% 59.0% 59.04%
Operating Margin -1.1% -85.5% -62.5% -50.2% -87.9% -79.9% -79.90%
Net Margin -1.6% -72.6% -52.1% -41.9% -79.3% -73.1% -73.10%
EBITDA Margin -1.0% -69.8% -49.6% -39.0% -76.8% -76.4% -76.41%
FCF Margin -1.2% -87.3% -67.1% -56.1% -55.4% -51.6% -51.60%
OCF Margin -1.1% -82.1% -62.1% -50.8% -49.7% -46.9% -46.89%
ROIC Economic snapshot only -25.18%
Cash ROA snapshot only -19.09%
Cash ROIC snapshot only -67.74%
CROIC snapshot only -74.54%
NOPAT Margin snapshot only -55.11%
Pretax Margin snapshot only -61.31%
R&D / Revenue snapshot only 32.70%
SGA / Revenue snapshot only 95.36%
SBC / Revenue snapshot only 17.82%
Valuation
Metric Trend Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -13.12 -13.88 -14.51 -16.87 -6.70 -9.57 -11.286
P/S Ratio 21.31 15.46 12.73 12.32 4.04 5.87 7.167
P/B Ratio 1.20 2.09 2.94 4.29 1.64 2.72 3.294
P/FCF -18.51 -17.71 -18.98 -21.97 -7.28 -11.37 -11.366
P/OCF — — — — — — —
EV/EBITDA -8.40 -11.35 -13.52 -17.05 -3.98 -7.30 -7.305
EV/Revenue 8.59 9.51 9.48 10.26 2.29 4.40 4.403
EV/EBIT -8.12 -10.95 -12.99 -16.28 -3.80 -6.97 -6.974
EV/FCF -7.46 -10.89 -14.14 -18.29 -4.13 -8.53 -8.533
Earnings Yield -7.6% -7.2% -6.9% -5.9% -14.9% -10.5% -10.45%
FCF Yield -5.4% -5.6% -5.3% -4.6% -13.7% -8.8% -8.80%
PEG Ratio snapshot only 9.183
Price/Tangible Book snapshot only 2.723
EV/Gross Profit snapshot only 7.551
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 15.88 14.68 10.64 8.66 10.69 8.88 8.880
Quick Ratio 14.93 13.79 9.83 7.96 9.67 7.96 7.961
Debt/Equity 0.02 0.02 0.03 0.04 0.03 0.03 0.025
Net Debt/Equity -0.72 -0.81 -0.75 -0.72 -0.71 -0.68 -0.679
Debt/Assets 0.02 0.02 0.02 0.04 0.02 0.02 0.022
Debt/EBITDA -0.39 -0.20 -0.16 -0.21 -0.11 -0.09 -0.091
Net Debt/EBITDA 12.45 7.10 4.63 3.42 3.03 2.43 2.425
Interest Coverage — — — — — — —
Equity Multiplier 1.08 1.09 1.12 1.14 1.12 1.14 1.141
Cash Ratio snapshot only 6.937
Cash to Debt snapshot only 27.716
FCF to Debt snapshot only -9.430
Defensive Interval snapshot only 480.0 days
Efficiency & Turnover
Metric Trend Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.05 0.12 0.21 0.30 0.34 0.38 0.382
Inventory Turnover 0.55 1.12 1.55 2.06 2.39 2.41 2.406
Receivables Turnover 1.60 3.59 5.90 5.86 8.24 8.08 8.083
Payables Turnover 2.51 5.67 7.07 8.95 16.37 11.31 11.307
DSO 228 102 62 62 44 45 45.2 days
DIO 662 326 236 177 152 152 151.7 days
DPO 145 64 52 41 22 32 32.3 days
Cash Conversion Cycle 745 363 246 199 174 165 164.6 days
Fixed Asset Turnover snapshot only 7.185
Operating Cycle snapshot only 196.9 days
Cash Velocity snapshot only 0.659
Capital Intensity snapshot only 2.457
Growth (YoY)
Metric Trend Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue — — — — 5.2% 1.9% 1.91%
Net Income — — — — -1.3% -60.3% -60.29%
EPS — — — — -60.3% -56.1% -56.14%
FCF — — — — -2.0% -72.1% -72.11%
EBITDA — — — — -2.5% -1.1% -1.09%
Op. Income — — — — -3.1% -1.2% -1.16%
OCF Growth snapshot only -66.25%
Asset Growth snapshot only -11.39%
Equity Growth snapshot only -15.01%
Debt Growth snapshot only -2.62%
Shares Change snapshot only 2.66%
Growth Quality
Metric Trend Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability — — — — — — —
Earnings Stability — — — — — — —
Margin Stability — — — — — — —
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.500
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0
Earnings Persistence — — — — — — —
Earnings Smoothness — — — — — — —
ROE Trend — — — — — — —
Gross Margin Trend — — — — — — —
FCF Margin Trend — — — — — — —
Sustainable Growth Rate — — — — — — —
Internal Growth Rate — — — — — — —
Cash Flow Quality
Metric Trend Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.70 0.74 0.71 0.70 0.82 0.76 0.765
FCF/OCF 1.02 1.06 1.08 1.10 1.12 1.10 1.100
FCF/Net Income snapshot only 0.842
CapEx/Revenue 1.9% 5.2% 5.0% 5.3% 5.8% 4.7% 4.71%
CapEx/Depreciation snapshot only 1.644
Accruals Ratio -0.03 -0.04 -0.05 -0.07 -0.04 -0.06 -0.055
Sloan Accruals snapshot only -0.209
Cash Flow Adequacy snapshot only -9.964
Dividends & Buybacks
Metric Trend Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — —
FCF Payout Ratio — — — — — — —
Total Payout Ratio — — — — — — —
Div. Increase Streak — — — — — — —
Chowder Number — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -56.1% -33.4% -24.6% -17.4% -1.0% -0.9% -0.88%
Total Shareholder Return -56.1% -33.4% -24.6% -17.4% -1.0% -0.9% -0.88%
DuPont Factors
Metric Trend Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.54 1.28 1.20 1.16 1.00 0.97 0.971
EBIT Margin -1.06 -0.87 -0.73 -0.63 -0.60 -0.63 -0.631
Asset Turnover 0.05 0.12 0.21 0.30 0.34 0.38 0.382
Equity Multiplier 1.08 1.09 1.12 1.14 1.10 1.12 1.115
Per Share
Metric Trend Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-0.93 $-1.05 $-1.37 $-1.81 $-1.50 $-1.64 $-1.64
Book Value/Share $10.22 $6.95 $6.76 $7.10 $6.10 $5.76 $5.76
Tangible Book/Share $10.22 $6.95 $6.76 $7.10 $6.10 $5.76 $5.76
Revenue/Share $0.57 $0.94 $1.56 $2.47 $2.48 $2.67 $2.67
FCF/Share $-0.66 $-0.82 $-1.05 $-1.39 $-1.38 $-1.38 $-1.38
OCF/Share $-0.65 $-0.77 $-0.97 $-1.26 $-1.23 $-1.25 $-1.25
Cash/Share $7.54 $5.76 $5.24 $5.41 $4.49 $4.05 $4.05
EBITDA/Share $-0.59 $-0.79 $-1.10 $-1.49 $-1.43 $-1.61 $-1.61
Debt/Share $0.23 $0.15 $0.18 $0.31 $0.16 $0.15 $0.15
Net Debt/Share $-7.31 $-5.60 $-5.06 $-5.10 $-4.33 $-3.91 $-3.91
Academic Models
Metric Trend Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — 10.039
Altman Z-Prime snapshot only 18.590
Piotroski F-Score 2 2 2 2 3 3 3
Beneish M-Score — — — — -2.35 -2.02 -2.020
Ohlson O-Score snapshot only -5.673
ROIC (Greenblatt) snapshot only -33.91%
Net-Net WC snapshot only $4.38
EVA snapshot only $-73821540.00
Credit
Metric Trend Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only A
Credit Score 74.76 74.60 74.84 74.45 74.63 74.72 74.722
Credit Grade snapshot only 6
Credit Trend snapshot only 0.118
Implied Spread (bps) snapshot only 150.000
Industry Credit Rank snapshot only 71
Sector Credit Rank snapshot only 71

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms